Skip to main content
CMEducation Resources ScrollCall
  • menu
  • menu
  • person
  • Search
  • Specialty
  • Cardiology chevron_right

  • Specialty Program
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Pain Management chevron_right
  • Glycemic Regulation chevron_right
  • PCSK9s in Interventional Cardiology chevron_right
  • PCSK9s in Medical Preventative chevron_right
  • PCSK9s in Lipid Medicine & Atherosclerosis Prevention chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • PCSK9s: A Multi-Specialty Perspective chevron_right
  • Specialty
  • Diabetes chevron_right

  • Specialty Program
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Glycemic Regulation chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • Specialty Program
  • Congenital Adrenal Hyperplasia (CAH) chevron_right
  • Cytokine Immunotherapy chevron_right
  • Hypothyroidism chevron_right
  • Specialty Program
  • Parkinson's Diseasechevron_right
  • Specialty
  • Cancer chevron_right

  • Specialty Program
  • Cytokine Immunotherapy chevron_right
  • Extracorporeal Photopheresis (ECP) chevron_right
  • Pain Management chevron_right
  • Specialty
  • Primary Care chevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Congenital Adrenal Hyperplasia (CAH) chevron_right
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Parkinson's Diseasechevron_right
  • Pain Management chevron_right
  • Glycemic Regulation chevron_right
  • Specialty
  • Dermatology chevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Cytokine Immunotherapy chevron_right
  • Fabry Disease chevron_right
  • Extracorporeal Photopheresis (ECP) chevron_right
  • Specialty
  • Biologicschevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Cytokine Immunotherapy chevron_right
  • Fabry Disease chevron_right
  • Biosimilars for RA chevron_right
  • PCSK9s in Interventional Cardiology chevron_right
  • PCSK9s in Medical Preventative chevron_right
  • PCSK9s in Lipid Medicine & Atherosclerosis Prevention chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • PCSK9s: A Multi-Specialty Perspective chevron_right
  • Specialty
  • MAC Lung Disease chevron_right

  • Specialty Program
  • MAC Lung Disease chevron_right
    • close
    CMEducation Resources iQ&A
    • person
    • Home
    • Specialtieschevron_right
      • chevron_leftTopics
      • Cardiology
      • Diabetes
      • Endocrinology
      • Neurology
      • Cancer
      • Primary Care
      • Dermatology
      • Biologics
      • MAC Lung Disease
    • Submit A Question
    close

    Jeff Gadsden, MD

    Jeff Gadsden, MD

    Associate Professor
    Duke University School of Medicine
    Chief, Division of Orthopaedic, Plastic and Regional Anesthesiology
    Duke University Medical Center
    Chapel Hill, North Carolina


    Related Videos

    What did the TKR orthopedic study by Sinatra and colleagues show about the pain relieving properties of IV acetaminophen (four doses) and its effect on rescue opioid use and reduction of total morphine usage? Video

    What did the TKR orthopedic study by Sinatra and colleagues show about the pain relieving properties of IV acetaminophen (four doses) and its effect on rescue opioid use and reduction of total morphine usage?

    What did the TKR orthopedic study by Sinatra and colleagues show about the pain relieving properties of IV acetaminophen (four doses) and its effect on rescue opioid use and reduction of total morphine usage?

    What are the effects of IV opioids on gastric emptying, transit, and GI absorption of IV acetaminophen versus oral acetaminophen? Video

    What are the effects of IV opioids on gastric emptying, transit, and GI absorption of IV acetaminophen versus oral acetaminophen?

    What are the effects of IV opioids on gastric emptying, transit, and GI absorption of IV acetaminophen versus oral acetaminophen? What is the clinical and PK impact of giving concomitant opioids on these two routes of acetaminophen administration?

    Since a significant effect of acetaminophen is on central CNS receptors, what do studies measuring CSF levels show regarding IV administration of acetaminophen? Video

    Since a significant effect of acetaminophen is on central CNS receptors, what do studies measuring CSF levels show regarding IV administration of acetaminophen?

    Since a significant effect of acetaminophen is on central CNS receptors, what do studies measuring CSF levels show regarding IV administration of acetaminophen? What do AUC results show and what is the significance of these findings clinically?

    What do T-max-focused studies show about the advantages of the IV route of administration of acetaminophen over oral and other formulations? Video

    What do T-max-focused studies show about the advantages of the IV route of administration of acetaminophen over oral and other formulations?

    What do T-max-focused studies show about the advantages of the IV route of administration of acetaminophen over oral and other formulations?

    What are the implications of IV acetaminophen having 100% bioavailability versus the oral formulation which undergoes first pass hepatic metabolism? Video

    What are the implications of IV acetaminophen having 100% bioavailability versus the oral formulation which undergoes first pass hepatic metabolism?

    What are the implications of IV acetaminophen having 100% bioavailability versus the oral formulation which undergoes first pass hepatic metabolism? How does this affect C-max and what are the clinical implications?

    If you have a surgical patient who is on both IV acetaminophen and an IV opioid and the patient becomes intolerant to the opioid, can you continue the IV acetaminophen alone as monotherapy? Video

    If you have a surgical patient who is on both IV acetaminophen and an IV opioid and the patient becomes intolerant to the opioid, can you continue the IV acetaminophen alone as monotherapy?

    If you have a surgical patient who is on both IV acetaminophen and an IV opioid and the patient becomes intolerant to the opioid, can you continue the IV acetaminophen alone as monotherapy and/or what other non-opioid might you add to achieve synergies?

    Can you compare and contrast the efficacy and safety of IV acetaminophen with the other IV non-opioid agents that are sometimes used in conjunction with IV opioids? Video

    Can you compare and contrast the efficacy and safety of IV acetaminophen with the other IV non-opioid agents that are sometimes used in conjunction with IV opioids?

    Can you compare and contrast the efficacy and, especially, the safety of IV acetaminophen with the other IV non-opioid agents that are sometimes used in conjunction with IV opioids? Why do you consider acetaminophen the “backbone” of multimodal analgesia?

    In what specific surgical procedures is IV acetaminophen indicated as a core agent in the context of multimodal management and ERAS? And what are the indications for this agent? Video

    In what specific surgical procedures is IV acetaminophen indicated as a core agent in the context of multimodal management and ERAS? And what are the indications for this agent?

    In what specific surgical procedures — from orthopedics to colorectal surgery — is IV acetaminophen indicated as a core agent in the context of multimodal management and ERAS? And what are the indications for this agent?

    What dosing schedule do you recommend for acetaminophen? Why do you feel that IV acetaminophen is preferable to oral and what is the effect of IV opioids on absorption and blood levels? Video

    What dosing schedule do you recommend for acetaminophen? Why do you feel that IV acetaminophen is preferable to oral and what is the effect of IV opioids on absorption and blood levels?

    What is the exact dosing schedule you recommend and use for acetaminophen? Why do you feel that IV acetaminophen is preferable to the oral formulation and what is the effect of IV opioids on absorption and blood levels or oral acetaminophen? ...

    Disclaimer:
    Copyright © by CMEducation Resources, LLC All rights reserved. Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
    Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.
    Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.
    Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

    Clinical Webcasts®

    Powered by BroadcastMedBROADCASTMED